Bionano Genomics, Inc. Total Liabilities and Equity
Bionano Genomics, Inc. (BNGO) had Total Liabilities and Equity of $47.59 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-10
- 2026-06-30: Liabilities and Equity $47.59M.
- 2026-03-31: Liabilities and Equity $64.80M.
- 2025-12-31: Liabilities and Equity $73.58M.
- 2025-09-30: Liabilities and Equity $79.06M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $47.59M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | $64.80M 10-Q · filed 2026-05-13 | |
| 2025-12-31 | $73.58M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | $79.06M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | $76.01M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $78.41M 10-Q · filed 2025-05-14 | |
| 2024-12-31 | $76.67M 10-K · filed 2026-03-23 | |
| 2024-09-30 | $87.36M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $129.36M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $158.00M 10-Q · filed 2024-05-08 | |
| 2023-12-31 | $214.40M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $181.90M 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $271.38M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $292.15M 10-Q · filed 2023-05-09 | |
| 2022-12-31 | $307.50M 10-K · filed 2024-03-05 | |
| 2022-09-30 | $323.70M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $321.55M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $348.21M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $377.10M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $359.66M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $356.81M 10-Q · filed 2021-08-04 | |
| 2021-03-31 | $384.86M 10-Q · filed 2021-05-13 | |
| 2020-12-31 | $60.45M 10-K · filed 2022-03-01 | $60.45M 10-K · filed 2021-03-23 |
| 2020-09-30 | $41.40M 10-Q · filed 2020-11-13 | |
| 2020-06-30 | $27.20M 10-Q · filed 2020-08-13 | |
| 2020-03-31 | $19.10M 10-Q · filed 2020-06-18 | |
| 2019-12-31 | $30.21M 10-K · filed 2021-03-23 | |
| 2019-09-30 | $19.21M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $25.21M 10-Q · filed 2019-08-08 | |
| 2019-03-31 | $29.55M 10-Q · filed 2019-05-09 | |
| 2018-12-31 | $24.80M 10-K · filed 2020-03-10 | |
| 2018-09-30 | $30.67M 10-Q · filed 2018-11-07 | |
| 2017-12-31 | $10.15M 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ASTROTECH Corp (ASTC) | United States | $0.013B | |
| HARVARD BIOSCIENCE INC (HBIO) | United States | $0.037B | -2.70 |
| Precipio, Inc. (PRPO) | United States | $0.043B | -36.70 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |